MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-01-0038369
Unimerk Pharma Private Limited
Unimerk Pharma Private Limited - chemicals in Agra, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹41.49 Lakh
▼ 6% YoY
Net profit · FY 2025
₹48,000
Net margin 1.2%
EBITDA · FY 2025
₹2.14 Lakh
EBITDA margin 5.2%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Unimerk Pharma Private Limited
Data last updated:
Unimerk Pharma Private Limited is a private limited company based in Agra, Uttar Pradesh, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 13 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U74999UP2016PTC088283. Its GSTIN is 09AACCU0208P1Z5 (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Archana and Rajesh Kumar Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 9/19 Rui Ki Mandi Tajganj, Agra, Uttar Pradesh, India – 282001.
As per the financials filed for FY 2025, the company reported a revenue of ₹41.49 Lakh, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹48,000 (net margin 1.2%) and EBITDA of ₹2.14 Lakh (EBITDA margin 5.2%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 30% over five years.
Unimerk Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-01-0038369). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999UP2016PTC088283
Registration Number 088283
Incorporation Date 13 December 2016
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-01-0038369
Key People
Archana Director Rajesh Kumar Sharma Director Recognitions & Rankings of Unimerk Pharma
Contact details
Unimerk Pharma Private Limited's registered office is in Agra, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address9/19 Rui Ki Mandi Tajganj, Agra, Uttar Pradesh, India – 282001
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Unimerk Pharma Private Limited, buy the company report.
Comprehensive company report
Unimerk Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Unimerk Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Unimerk Pharma Private Limited, buy the company report.
Financials of Unimerk Pharma Private Limited
FY 2025 filings availableUnimerk Pharma Private Limited reported revenue of ₹41.49 Lakh (down 6% YoY) for FY 2025.
Revenue · FY 2025
₹41.49 Lakh ▼ 6%
Net profit · FY 2025
₹48,000 margin 1.2%
EBITDA · FY 2025
₹2.14 Lakh margin 5.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 6%
3 years · compounded
▲ 12%
5 years · compounded
▲ 30%
EBITDA CAGR growth
1 year
▲ 56%
3 years · compounded
▲ 52%
5 years · compounded
▲ 109%
Revenue fell 6% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 30%. EBITDA rose 56% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.14 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹48,000 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.2% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Unimerk Pharma Private Limited, buy the company report.
Board of directors of Unimerk Pharma Private Limited
Unimerk Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Archana | Director | 13 Dec 2016 | 9 Years 10 Months | Current |
| Rajesh Kumar Sharma | Director | 13 Dec 2016 | 9 Years 10 Months | Current |
Peer comparison
Unimerk Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dheeraj Jewellers Private Limited | ₹41.52 Lakh (FY 2025) | -27.0% | Rewa, Madhya Pradesh, India | |||
| Suvan Infraprojects Private Limited | ₹41.5 Lakh (FY 2021) | 176.0% | Howrah, West Bengal, India | |||
| Biogreening Services and Consultancy Private Limited | ₹41.5 Lakh (FY 2025) | 48.0% | Kendrapada, Odisha, India | |||
| Mundrika Saw Jewellers Private Limited | ₹41.5 Lakh (FY 2024) | 292.0% | Daltonganj, Jharkhand, India | |||
| Nici Skin Care Private Limited | ₹41.49 Lakh (FY 2024) | -5.0% | Mumbai, Maharashtra, India | |||
| Unimerk Pharma Private Limitedthis company | ₹41.49 Lakh (FY 2025) | ₹48,000 | 1.2% | -6.0% | Agra, Uttar Pradesh, India | |
| Chhajed Jewellers Private Limited | ₹41.47 Lakh (FY 2025) | 126.0% | Ratlam, Madhya Pradesh, India | |||
| Form Fever Technologies Private Limited | ₹41.46 Lakh (FY 2024) | -18.0% | Gurugram, Haryana, India | |||
| Digoyat Talent Management Service (OPC) Private Limited | ₹41.45 Lakh (FY 2021) | 190.0% | Rohtak, Haryana, India | |||
| Om Sri Digital Private Limited | ₹41.44 Lakh (FY 2025) | -64.0% | Hyderabad, Telangana, India | |||
| Adlok Creations Private Limited | ₹41.44 Lakh (FY 2024) | -65.0% | Mandir, New Delhi, Delhi, India |
To see the full peer comparison of Unimerk Pharma Private Limited, buy the company report.
Auditor
Unimerk Pharma Private Limited is audited by K.G. & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K.G. & ASSOCIATES | FY 2017 | 014871C |
Shareholding
The shareholding of Unimerk Pharma Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Unimerk Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Unimerk Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unimerk Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Unimerk Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AACCU0208P1Z5 | Uttar Pradesh | Active | 25 Aug 2021 |
To see the full GST registrations and return filing status of Unimerk Pharma Private Limited, buy the company report.
Recent activity
Unimerk Pharma Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Archana was appointed as Director on 13 Dec 2016.
AGM
Unimerk Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Unimerk Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Appointed
Archana was appointed as Director.
Appointed
Rajesh Kumar Sharma was appointed as Director.
Incorporation
13 Dec 2016
Unimerk Pharma Private Limited was registered on 13 Dec 2016 with Roc Kanpur & aged 9 years 10 months as per MCA records.
Frequently asked questions
Unimerk Pharma is an active private limited company based in Agra, Uttar Pradesh, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 13 December 2016 (10+ years old) and is registered under CIN U74999UP2016PTC088283.
Unimerk Pharma has 2 current directors:
- Archana - Director
- Rajesh Kumar Sharma - Director
The latest financial statements of Unimerk Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Unimerk Pharma is 09AACCU0208P1Z5, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Unimerk Pharma is U74999UP2016PTC088283. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unimerk Pharma was incorporated on 13 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Unimerk Pharma by revenue are Dheeraj Jewellers Private Limited, Suvan Infraprojects Private Limited, Biogreening Services and Consultancy Private Limited, Mundrika Saw Jewellers Private Limited, Nici Skin Care Private Limited and 5 more, all in the same principal business activity (retail trading).
Archana was appointed as Director on 13 Dec 2016. Rajesh Kumar Sharma was appointed as Director on 13 Dec 2016.
Yes, Unimerk Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-01-0038369).
The registered office of Unimerk Pharma is at 919 Rui Ki Mandi Tajganj, Agra, Uttar Pradesh, India – 282001.
Unimerk Pharma operates in the chemicals industry, in the medicinal chemical and botanical products segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages